Medcxy

Product dossierBuilt from registrations, label text and platform-curated data

RetoxinRetoxin (recombinant botulinum toxin A) 100U

Ask about this product

Retoxin is a Botulinum toxin type A product (Drug), registered by 重庆誉颜制药有限公司. Linked registrations: China 国药准字S20260019. First approved in China on 2026-03-25 (国药准字S20260019). Data as of 2026-10-24.

  • Regulatory classBotulinum toxin type A · Drug
  • Holder重庆誉颜制药有限公司
  • JurisdictionsCN
  • Updated2026-10-24 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

Retoxin

Product
Regulatory class
Drug
Category
Botulinum toxin type A
China · NMPA drug approval
国药准字S20260019
Name on registration
注射用重组A型肉毒毒素
Registrant
重庆誉颜制药有限公司
First approval
2026-03-25
This certificate issued
2026-03-25
Models and sizes
100单位/支
Checked against official page
2026-10-23

Public: fields from the registration record.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. CN

    国药准字S20260019 first approved

  2. CN

    国药准字S20260019 change

    首次获批（受理号 CXSS2400144；2026年03月27日药品批准证明文件送达信息）

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

1
  • 国药准字S20260019: 首次获批（受理号 CXSS2400144；2026年03月27日药品批准证明文件送达信息）2026-03-25

Sources

1